2 completed, 1 terminated, 1 unknown, 1 withdrawn. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow D-Pharm Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA THR-18, Placebo, Tissue Plasminogen Activator (tPA) - Ischemic Stroke | Phase 2 | Unknown | D-Pharm Ltd. | 40 | 2015-10-01 | 2015-11-17 |
| DP-b99 in the Treatment of Acute High-risk Pancreatitis DP-b99, Placebo - Pancreatitis | Phase 2 | Terminated | D-Pharm Ltd. | 10 | 2013-12-01 | 2015-06-23 |
| THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA THR-18, Placebo - Stroke, Acute | Phase 2 | Completed | D-Pharm Ltd. | 30 | 2013-10-01 | 2015-02-04 |
| DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study DP-VPA, DP-VPA Placebo - Migraine | Phase 2 | Withdrawn | D-Pharm Ltd. | 40 | 2008-07-01 | 2009-05-05 |
| Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke DP-b99 - Brain Ischemia, Stroke | Phase 2 | Completed | D-Pharm Ltd. | 150 | 2005-02-01 | 2007-11-26 |
Stroke (2) · Brain Infarction (1) · Brain Ischemia (1) · Cerebrovascular Disorders (1) · Ischemic Stroke (1) · Migraine Disorders (1) · Pancreatitis (1)
DP-b99 (2) · DP-VPA (1) · Tissue Plasminogen Activator (1)
Israel (2) · Czechia (1) · Germany (1) · Moldova (1) · Ukraine (1)
Gilad Rosenberg, M.D. (2) · Gilad Rosenberg, MD (1)